SCHEMBL7073348

SCHEMBL7073348

Cc1cccc(CC2CC3CCC(C2)N3Cc2nc3ccccc3[nH]2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 4/20 0.53
GRIN2B Q13224 4/20 0.53
HTT P42858 2/20 0.48
ALPL P05186 1/20 0.48
ALPI P09923 1/20 0.48
MAPT P10636 1/20 0.48
ALPG P10696 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CXCR6 O00574 1/20 0.47
DRD4 P21917 3/20 0.44
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
KCNH2 Q12809 1/20 0.43
GAA P10253 1/20 0.42
IDO1 P14902 2/20 0.41
CACNA1H O95180 1/20 0.41
HTR1A P08908 1/20 0.41
ADRA2C P18825 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7074921 0.88 GRIN2B (0.56) GRIN1GRIN2BHTTKMT2ASMN1; SMN2
SCHEMBL7072578 0.88 GRIN2B (0.67) GRIN1GRIN2BHTTSMN1; SMN2CXCR6
SCHEMBL7072074 0.88 GRIN1 (0.53) GRIN1GRIN2BHTTMAPTKMT2A
SCHEMBL7076802 0.88 GRIN2B (0.56) GRIN1GRIN2BHTTMAPTKMT2A
SCHEMBL7079118 0.83 GRIN1 (0.50) GRIN1GRIN2BHTTCXCR6DRD4
SCHEMBL7071858 0.82 MEN1 (0.49) GRIN1GRIN2BHTTKMT2ACXCR6
SCHEMBL7075826 0.82 GRIN1 (0.56) GRIN1GRIN2BHTTMAPTKMT2A
SCHEMBL7074975 0.82 GRIN1 (0.56) GRIN1GRIN2BHTTKMT2ASMN1; SMN2
SCHEMBL7072398 0.81 GRIN1 (0.53) GRIN1GRIN2BKMT2ASMN1; SMN2CXCR6
SCHEMBL7077264 0.78 GRIN1 (0.54) GRIN1GRIN2BHTTSMN1; SMN2CXCR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP claimed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP claimed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US claimed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO claimed
EP-1244450-A4 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2003-03-19 EP disclosed
EP-1244450-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-10-02 EP disclosed
US-6432976-B1 ANALGESICS; SIDE EFFECT REDUCTION MERCK & CO., INC. 2002-08-13 US disclosed
WO-2001032179-A1 8-AZA-BICYCLO[3.2.1]OCTANE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed